探讨DCE-MRI相较于T2和DWI在准确评估根治性前列腺切除术后定义的临床显著性外周带前列腺病灶PI-RADS v2评分中的作用
回顾性纳入271例经病理证实前列腺癌并接受3T mpMRI及根治性前列腺切除术的患者,评估DCE-MRI对DWI评分为3分的外周带病灶的重新分类频率及诊断准确性。DCE使29/45例DWI3病灶升级为PI-RADS v2 4分,与最终病理相比,DCE升级评估的正确率为68.9%±7%(31/45)。
要点
- DWI3外周带病灶中,DCE阳性者升级为PI-RADS v2 4分,提示临床显著性前列腺癌。
- DCE对DWI3病灶升级评估与最终病理一致的准确率为68.9%±7%(31/45)。
- 临床显著性前列腺癌定义为Gleason评分≥7或病理证实的包膜外侵犯。
核心结论
- DCE可提高多数DWI评估为不确定PI-RADS v2评分的外周带病灶中临床显著性前列腺癌的检出准确性。
研究设计与样本
- 回顾性研究,纳入271例经病理证实前列腺癌、行3T前列腺多参数MRI并随后接受根治性前列腺切除术的患者;由知晓前列腺癌诊断但对最终病理不知情的放射科医生确定PI-RADS v2评估类别。
关键影像表现/征象
- 临床显著性前列腺癌在212/271(78.2%)例病理标本中发现,其中209例位于外周带。
- 45/209例外周带病灶因DWI评分为3分需DCE进一步分类。
- DCE阳性29/45例,将最终PI-RADS v2评估类别提升至4类;DCE阴性16/45例。
诊断标准与关键数值
- 临床显著性前列腺癌定义为病理Gleason评分≥7或包膜外侵犯。
- PI-RADS v2规定DWI评分为3分的外周带病灶,DCE阳性使总体评估评分升至4分,提示临床显著性前列腺癌。
- DCE升级评估与最终病理相比正确率为68.9%±7%(31/45)。
临床应用与阅片要点
- 对外周带DWI评分为3分的病灶,应结合DCE结果按PI-RADS v2规则决定是否升级为4分。
- DCE阳性可将DWI3外周带病灶升级为PI-RADS v2 4分,提示临床显著性前列腺癌。
- DCE阴性时DWI3病灶不升级,但原文未报告阴性病例的最终病理分布。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: PI-RADS v2 dictates that dynamic contrast-enhanced (DCE) imaging be used to further classify peripheral zone (PZ) cases that receive a diffusion-weighted imaging equivocal score of three (DWI3), a positive DCE resulting in an increase in overall assessment score to a four, indicative of clinically significant prostate cancer (csPCa). However, the accuracy of DCE in predicting csPCa in DWI3 PZ cases is unknown. This study sought to determine the frequency with which DCE changes the PI-RADS v2 DWI3 assessment category, and to determine the overall accuracy of DCE-MRI in equivocal PZ DWI3 lesions.
MATERIALS AND METHODS: This is a retrospective study of patients with pathologically proven PCa who underwent prostate mpMRI at 3T and subsequent radical prostatectomy. PI-RADS v2 assessment categories were determined by a radiologist, aware of a diagnosis of PCa, but blinded to final pathology. csPCa was defined as a Gleason score ≥ 7 or extra prostatic extension at pathology review. Performance characteristics and diagnostic accuracy of DCE in assigning a csPCa assessment in PZ lesions were calculated.
RESULTS: A total of 271 men with mean age of 59 ± 6 years mean PSA 6.7 ng/mL were included. csPCa was found in 212/271 (78.2%) cases at pathology, 209 of which were localized in the PZ. DCE was necessary to further classify (45/209) of patients who received a score of DWI3. DCE was positive in 29/45 cases, increasing the final PI-RADS v2 assessment category to a category 4, with 16/45 having a negative DCE. When compared with final pathology, DCE was correct in increasing the assessment category in 68.9% ± 7% (31/45) of DWI3 cases.
CONCLUSION: DCE increases the accuracy of detection of csPCa in the majority of PZ lesions that receive an equivocal PI-RADS v2 assessment category using DWI.
引用
- Taghipour M, Ziaei A, Alessandrino F, et al. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy. Abdom Radiol (NY). 2019. PMID: 30361870. doi:10.1007/s00261-018-1807-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。